Page last updated: 2024-09-03

pentosidine and Kidney Diseases

pentosidine has been researched along with Kidney Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marumo, K; Saito, M1
Alderson, NL; Baynes, JW; Beattie, RJ; Chachich, ME; Nachtigal, M; Thorpe, SR; Youssef, NN1
Chen, PY; Guo, ZJ; Hou, FF; Miyata, T; Owen, WF; Ren, H; Schmidt, AM; Zhang, X1
Horie, K; Kurokawa, K; Miyata, T; Nangaku, M; Tanaka, S; Ueda, Y; van Ypersele de Strihou, C1
D'Agati, VD; Fu, C; Kislinger, T; Markowitz, GS; Pischetsrieder, M; Schmidt, AM; Stern, D; Taguchi, A; Tanji, N1
Goto, C; Kasahara, Y; Koizumi, S; Miyata, T; Morimoto, K; Ohta, K; Seki, H; Shimizu, M; Toma, T; Yachie, A; Yang, Y; Yokoyama, H1

Reviews

1 review(s) available for pentosidine and Kidney Diseases

ArticleYear
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Bone quality in chronic kidney disease : enzymatic and non-enzymatic glycation or oxidation induced cross-links in bone].
    Clinical calcium, 2010, Volume: 20, Issue:7

    Topics: Animals; Arginine; Bone and Bones; Bone Diseases, Metabolic; Chronic Disease; Collagen; Fractures, Bone; Glycation End Products, Advanced; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Diseases; Lysine; Osteoporosis; Oxidative Stress; Risk

2010

Other Studies

5 other study(ies) available for pentosidine and Kidney Diseases

ArticleYear
The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats.
    Kidney international, 2003, Volume: 63, Issue:6

    Topics: Animals; Aorta; Arginine; Blood Glucose; Blood Pressure; Collagen; Female; Glycation End Products, Advanced; Hyperlipidemias; Hypertension; Kidney; Kidney Diseases; Lysine; Pyridoxamine; Rats; Rats, Zucker; Skin; Weight Gain

2003
Enhanced expression of receptor for advanced glycation end products in chronic kidney disease.
    Journal of the American Society of Nephrology : JASN, 2004, Volume: 15, Issue:7

    Topics: Adult; Arginine; Binding Sites; C-Reactive Protein; Chronic Disease; Female; Humans; Inflammation; Kidney Diseases; Kinetics; Ligands; Lysine; Male; Middle Aged; Monocytes; Protein Binding; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Time Factors; Tumor Necrosis Factor-alpha; Up-Regulation

2004
Renal catabolism of advanced glycation end products: the fate of pentosidine.
    Kidney international, 1998, Volume: 53, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Arginine; Chromatography, High Pressure Liquid; Gentamicins; Glycation End Products, Advanced; Kidney Diseases; Kidney Glomerulus; Kidney Tubules, Proximal; Lysine; Protein Synthesis Inhibitors; Rats; Rats, Wistar

1998
Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.
    Journal of the American Society of Nephrology : JASN, 2000, Volume: 11, Issue:9

    Topics: Adult; Antibodies; Arginine; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Humans; Immunohistochemistry; Kidney Diseases; Lysine; Male; Middle Aged; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reference Values; RNA, Messenger

2000
Cytoprotective role of heme oxygenase (HO)-1 in human kidney with various renal diseases.
    Kidney international, 2001, Volume: 60, Issue:5

    Topics: Adolescent; Aged; Arginine; Child; Cytoprotection; Hematuria; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Immunohistochemistry; Kidney; Kidney Diseases; Lysine; Membrane Proteins; Proteinuria

2001